The exact pre-treatment medical screen a responsible program runs — so you can ask for every item by name and know what "safe" actually looks like.
Before any serious program gives you a medicine like ibogaine, it checks your heart with an ECG (a "QTc" reading), tests three minerals in your blood — potassium, magnesium, and calcium — and goes over every medication you take plus your family's heart history. Ibogaine can throw even a healthy heart into a deadly rhythm, so these checks aren't red tape; they're what catches trouble before it starts. They lower the risk — they do not make it "safe," and ibogaine is still a Schedule I drug the FDA has not approved. If a place offers to dose you with no baseline ECG and no heart monitoring, that's your cue to walk out.
You've earned the right to ask hard questions about anything going into your body. This lesson hands you the concrete medical checklist a serious program runs before treatment — not as red tape, but as the thing that stands between you and a preventable tragedy. Learn each item well enough to ask for it out loud.
The single most important pre-treatment test is a baseline ECG (electrocardiogram) that measures your QTc — the time your heart's electrical system takes to reset between beats. A long QTc is the warning sign for a dangerous rhythm called Torsades de Pointes. This matters most for ibogaine: at the doses used in treatment settings it prolongs the QTc and can trigger potentially fatal ventricular arrhythmias Established — even in people with no prior heart disease.[1]
This is not a theoretical worry. In a supervised study of opioid-dependent patients, a single 10 mg/kg dose of ibogaine prolonged the QTc by an average of about 95 milliseconds, and half of the participants crossed a QTc of 500 ms — the threshold clinicians treat as a red-alert danger zone — alongside severe temporary loss of coordination.[2]
Your heart's electrical stability depends on three minerals in your blood: potassium (K), magnesium (Mg), and calcium (Ca). When any of these run low, the QT interval stretches and the arrhythmia risk climbs — so a good team draws these labs and corrects them before dosing, not after. Veterans on diuretics ("water pills"), or anyone who has been vomiting, sweating hard, or eating poorly, can be low without feeling it. Ask for these three by name.
Numbers on a page aren't the whole story. A thorough intake asks about your personal and family cardiac history: any history of fainting (especially during exertion), palpitations, heart attack, congenital heart conditions, or — the big one — sudden unexplained death in a blood relative under 50, which can flag an inherited rhythm disorder. Bring this history written down. A hands-on exam and, when indicated, a specialist referral are part of a real screen, not an upsell.
"Reconciliation" means the team builds one complete, verified list of everything you take — prescriptions, over-the-counter drugs, supplements, and protein powders. This matters for two reasons. First, many common medications independently prolong the QT interval, stacking risk on top of a cardiotoxic medicine. Second, your genetics change how you process drugs.
An enzyme called CYP2D6 is a major pathway your liver uses to break down ibogaine and many antidepressants. People carry different genetic versions of it, and that variation changes drug levels, effectiveness, and side effects — which is why pharmacogenetic guidelines now use CYP2D6 (and CYP2C19) status to guide antidepressant dosing.[3] A "slow metabolizer" can end up with far higher, longer-lasting drug levels than expected — which is why CYP2D6 genotyping is part of a careful ibogaine workup, and why serotonergic medications (SSRIs, SNRIs, MAOIs) often require a physician-supervised taper on a specific timeline.[1]
A responsible program also screens for conditions that make treatment unsafe: significant liver impairment (the liver processes ibogaine), active or unstable heart disease, pregnancy, and a personal or family history of psychosis or bipolar disorder, since psychedelics can precipitate mania or psychotic episodes in vulnerable people. Answering these honestly protects you — a "no" that saves your life is a good outcome, not a rejection.
You may hear that an aggressive cleanse or chelation protocol will "prepare your terrain" and improve results. Be careful. The idea that pre-treatment detox improves psychedelic outcomes is a Hypothesis, not a proven benefit — and a widely cited claim that these medicines raise BDNF (a brain-growth protein) in humans was not supported by a 2024 human meta-analysis, which found no change in blood BDNF levels. More concerning: hammering your body with a harsh detox or chelation right before a drug that stresses the heart can add risk by disturbing the very electrolytes your rhythm depends on. Real preparation is test-first and physician-timed, never "more cleanse equals more safety."
Carry this out of the lesson: Screening isn't a hurdle between you and the care you're weighing — it's how a responsible team lowers the risk of serious harm, so insist on every check by name.
Evidence surfaced via Consensus (consensus.app).
Operation Whole Health — Patriot-founded 501(c)(3). Patient Track · Module 07 — DRAFT v0.1. Educational only; not medical advice, and not an endorsement of any substance. Clinical decisions belong to your treating clinician; content marked for clinician sign-off is not final until a named physician approves it.
In crisis? Veterans Crisis Line: dial 988, then press 1.